Showing 121 - 130 of 355,199
Despite the intended support of the Agreement on Trade-Related Aspects of Intellectual Property Rights for the dissemination and transfer of Environmentally Sound Technologies to developing countries, Agreement has been criticized by developing countries for actually impeding the access and...
Persistent link: https://www.econbiz.de/10014121602
Persistent link: https://www.econbiz.de/10014022474
The COVID pandemic has energised opponents of the WTO TRIPS Agreement, who have long wished to weaken permanently intellectual property (IP) rules.But opposition to TRIPS ignores the huge benefits brought to WTO members by enabling increased participation in the global economy and facilitating...
Persistent link: https://www.econbiz.de/10013306881
the ongoing development and manufacture of COVID-19 vaccines and therapeutics provides real-world confirmation of the … collaborations that are essential to producing the billions of vaccine doses needed in the coming months, while leaving the world …
Persistent link: https://www.econbiz.de/10013311289
Rights (TRIPS Agreement) and Public Health adopted by the World Trade Organization, we realize that its impact is beyond …
Persistent link: https://www.econbiz.de/10014441903
The 12th WTO Ministerial Conference adopted a Ministerial Decision on the TRIPS Agreement on 17 June 2022. This partially concluded almost two years of protracted discussions in response to a proposal by India and South Africa for a waiver from certain obligations under the TRIPS Agreement for...
Persistent link: https://www.econbiz.de/10013469582
The cusp of the twentieth anniversary of the WTO Doha Declaration on the TRIPS Agreement and Public Health (hereafter "the Declaration") was marked by a global pandemic. The Declaration and its iteration in the Agreement on Trade Related Aspects of Intellectual Property Rights (hereafter...
Persistent link: https://www.econbiz.de/10013469589
The major bone of contention between the developed and developing countries in the TRIPS negotiations was patents for pharmaceuticals. The US-led developed countries bloc argued in favour of patents for pharmaceuticals amidst opposition from Brazil, India and other countries. Ample evidence,...
Persistent link: https://www.econbiz.de/10013393634
Persistent link: https://www.econbiz.de/10003115244
Persistent link: https://www.econbiz.de/10009566022